Proqr Therapeutics
(PRQR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,360 | -9,540 | 260 | -16,120 | -13,380 |
| Depreciation Amortization | 370 | 120 | 100 | 160 | 80 |
| Other Working Capital | 520 | 0 | 0 | 1,440 | 0 |
| Other Operating Activity | -3,950 | -2,960 | -6,310 | -4,690 | 730 |
| Operating Cash Flow | $-19,420 | $-12,380 | $-5,950 | $-19,210 | $-12,570 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,210 | -600 | -550 | -1,470 | -780 |
| Other Investing Activity | -30 | -570 | 0 | -160 | 0 |
| Investing Cash Flow | $-1,240 | $-1,170 | $-550 | $-1,630 | $-780 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,380 | 1,370 | -8 | 159,360 | 158,880 |
| Financing Cash Flow | $1,380 | $1,370 | $-8 | $159,360 | $158,880 |
| Exchange Rate Effect | 5,130 | 5,160 | 7,730 | 138,500 | 1,930 |
| Beginning Cash Position | 125,440 | 124,700 | 127,240 | 5,480 | 5,470 |
| End Cash Position | 111,280 | 117,680 | 128,460 | 149,860 | 152,930 |
| Net Cash Flow | $-14,150 | $-7,020 | $1,210 | $144,370 | $147,450 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,420 | -12,380 | -5,950 | -19,210 | -12,570 |
| Free Cash Flow | -19,420 | -12,380 | -5,950 | -19,210 | -12,570 |